½ÃÀ庸°í¼­
»óǰÄÚµå
1642681

¼¼°èÀÇ ¼ö¼ú¿ë ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛ ½ÃÀå º¸°í¼­ : ±â¼ú, ¿ëµµ, ÃÖÁ¾ ¿ëµµ, Áö¿ªº°(2025-2033³â)

Surgical Navigation Systems Market Report by Technology, Application, End User, and Region 2025-2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 141 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼ö¼ú¿ë ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛ ½ÃÀå ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â 97¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2033³â±îÁö 225¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óÇϸç, 2025-2033³â°£ 9.76%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î Àü¸ÁÇϰí ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯ Áõ°¡, °í·ÉÈ­, ÃÖ¼Òħ½À(MI) ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¼ö¼ú¿ë ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛ¿¡ »õ·Î¿î ½Ã°¢È­ ±â¼úÀÇ ÅëÇÕ µîÀÌ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¼ö¼ú¿ë ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛ ½ÃÀå ºÐ¼® :

ÁÖ¿ä ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ: ¾Ï, Á¤Çü¿Ü°ú Áúȯ, ½Å°æ Áúȯ µî ¸¸¼º ÁúȯÀÇ ºÎ´ãÀÌ ±ÞÁõÇϸ鼭 ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼ö¼ú¿ë ³»ºñ°ÔÀÌ¼Ç ±â¼úÀÇ Áö¼ÓÀûÀÎ ¹ßÀüÀº ¿µ»ó ¾ç½ÄÀÇ °³¼±, ¼ÒÇÁÆ®¿þ¾î ¾Ë°í¸®ÁòÀÇ °­È­, Áõ°­Çö½Ç°úÀÇ ÅëÇÕ µî ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå µ¿Çâ : ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´×ÀÇ ÅëÇÕ, ÈÞ´ë¿ë ¹× ÇÚµåÇïµå ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛ ½ÃÀå °³Ã´¿¡ ´ëÇÑ ¼ºÇâ Áõ°¡, ¿µ»ó ¾ç½ÄÀÇ ¹ßÀü µîÀÌ ½ÃÀå ¼ö¿ä¸¦ È®´ëÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ÀÇ·á ÀÎÇÁ¶ó ÅõÀÚ Áõ°¡, ÷´Ü ÀÇ·á ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ÀÇ·á Á¾»çÀÚÀÇ ÀÎ½Ä Áõ°¡·Î ÀÎÇØ ¼ö¼ú¿ë ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛ ½ÃÀåµµ È®´ëµÇ°í ÀÖ½À´Ï´Ù.

°æÀï ȯ°æ: ¼ö¼ú¿ë ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛ ½ÃÀåÀÇ ÁÖ¿ä ¾÷ü·Î´Â Amplitude Surgical, B. Braun SE, Brainlab AG, Collin Medical, Fudan Digital Medical, Johnson &Johnson, Medtronic PLC, Siemens Healthcare Private Ltd, Medtronic PLC, Siemens Healthcare Private Limited, Stryker Corporation, Zimmer Biomet Holdings Inc. µîÀÌ ÀÖ½À´Ï´Ù.

Áö¸®Àû µ¿Çâ : º¸°í¼­¿¡ µû¸£¸é ºÏ¹Ì°¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ºÏ¹Ì´Â Àα¸ °í·ÉÈ­, ¸¸¼º Áúȯ Áõ°¡, ¿Ü°ú ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ±â¼ú Çõ½ÅÀÇ ¹ßÀü µî ´Ù¾çÇÑ ¿äÀÎÀ¸·Î ÀÎÇØ °¡Àå µÎµå·¯Áø Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ºÏ¹Ì´Â ÀÇ·á ºÐ¾ßÀÇ ±â¼ú Çõ½ÅÀÇ ÃÖÀü¼±¿¡ ÀÖÀ¸¸ç, ÀÌ´Â ¼ö¼ú¿ë ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛ¿¡µµ ÇØ´çµË´Ï´Ù. Çâ»óµÈ ¿µ»ó ¾ç½Ä, Çâ»óµÈ ¼ÒÇÁÆ®¿þ¾î ¾Ë°í¸®Áò, ´Ù¸¥ ¼ö¼ú µµ±¸¿ÍÀÇ ÅëÇÕ µî ³»ºñ°ÔÀÌ¼Ç ±â¼úÀÇ ²÷ÀÓ¾ø´Â ¹ßÀüÀº ¼ö¼ú¿ë ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛ ½ÃÀå ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

°í¹Î°ú ±âȸ: ¼ö¼ú¿ë ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛÀÇ ³ôÀº Ãʱ⠺ñ¿ë, ÅëÇÕÀÇ º¹À⼺, Àü¹® ±³À°ÀÇ Çʿ伺, ±ÔÁ¦ ´ëÀÀ µîÀÌ ½ÃÀåÀÌ Á÷¸éÇϰí ÀÖ´Â ÁÖ¿ä °úÁ¦ÀÔ´Ï´Ù. ±×·¯³ª ¼ö¼ú¿ë ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛ°ú ·Îº¿ ¼ö¼ú Ç÷§Æû ¹× µðÁöÅÐ ¼ö¼ú ±â¼úÀÇ ÅëÇÕÀº ¼ö¼úÀÇ Á¤È®¼º, ÀÚµ¿È­ ¹× ¼ö¼ú È¿À²À» Çâ»ó½Ãų ¼ö ÀÖ´Â ¸¹Àº ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛ Á¦Á¶¾÷ü¿Í ·Îº¿ ±â¾÷ÀÇ Çù·ÂÀº ÃÖ¼Ò Ä§½À ¼ö¼ú¿¡ ´ëÇÑ Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀ¸·Î À̾îÁ® ¾÷°è ¼ö¿ä¸¦ Áö¿øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¼ö¼ú¿ë ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛ ½ÃÀå µ¿Çâ :

±Ù°ñ°Ý°è ¹× ½Å°æ°è ÁúȯÀÇ ±Þ°ÝÇÑ Áõ°¡

¼¼°è Àα¸ÀÇ °í·ÉÈ­¿¡ µû¶ó ÅðÇ༺ °üÀý¿°, Ãß°£ÆÇ ÅðÇ༺ Áúȯ, ¾ËÃ÷ÇÏÀ̸Ӻ´, ÆÄŲ½¼º´°ú °°Àº ½Å°æÁúȯ µî ³ëÈ­¿Í °ü·ÃµÈ ÁúȯÀÌ ÀÚ¿¬ÀûÀ¸·Î Áõ°¡ÇÕ´Ï´Ù. °í·ÉÈ­ »çȸ´Â ±Ù°ñ°Ý°è Áúȯ°ú ½Å°æ°è Áúȯ Áõ°¡¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¼¼°èº¸°Ç±â±¸(WHO)°¡ 2022³â 7¿ù¿¡ ¹ßÇ¥ÇÑ º¸°í¼­¿¡ µû¸£¸é, °í·ÉÈ­·Î ÀÎÇØ ¾à 17¾ï 1,000¸¸ ¸íÀÌ ±Ù°ñ°Ý°è ÁúȯÀ» ¾Î°í ÀÖ´Ù°í ÇÕ´Ï´Ù. ÀÌ¿Í º°°³·Î, ¿µ»ó ¾ç½ÄÀÇ °³¼±, Áõ°­Çö½Ç°úÀÇ ÅëÇÕ, AI ±â¹Ý ³»ºñ°ÔÀÌ¼Ç ¾Ë°í¸®Áò µî ¼ö¼ú¿ë ³»ºñ°ÔÀÌ¼Ç ±â¼úÀÇ Áö¼ÓÀûÀÎ ¹ßÀüÀ¸·Î º¹ÀâÇÑ ±Ù°ñ°Ý°è ¹× ½Å°æ°è Áúȯ¿¡ ´ëÇÑ ¼ö¼ú ½Ã½ºÅÛÀÇ ´É·ÂÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ¿Ü°úÀÇ»çµéÀº ȯÀÚ ¿¹Èĸ¦ °³¼±Çϱâ À§ÇØ Ã·´Ü ±â´ÉÀ» °®Ãá ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛÀ» äÅÃÇÏ´Â °æÇâÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 12¿ù, Á¤¹ÐÀÇ·á¿ë ¿µ»ó ¹ÙÀÌ¿À¸¶Ä¿ ¼±µµ±â¾÷ÀÎ Äûºö(Quibim)Àº ÀΰøÁö´É(AI)À» ÅëÇØ MRI °Ë»ç µ¥ÀÌÅ͸¦ ÀÚµ¿À¸·Î ¼öġȭÇÏ¿© PACS¿¡ Á÷Á¢ Ç¥½ÃÇÏ´Â QP-BrainÀ» Ãâ½ÃÇÏ¿© ½Å°æÁúȯ ȯÀÚÀÇ ³ú¸¦ Á¤·®ÀûÀ¸·Î ºÐ¼®ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. Á¤·®Àû ºÐ¼®À» ¿ëÀÌÇÏ°Ô ÇÕ´Ï´Ù. ÀÌ¿Í ´õºÒ¾î, °¢±¹ Á¤ºÎ´Â Á÷Àå ³» ±Ù°ñ°Ý°è Áúȯ¿¡ ´ëÇÑ ÀνÄÀ» ³ôÀ̱â À§ÇÑ ÀÌ´Ï¼ÅÆ¼ºê¸¦ ÃëÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 1¿ù, ¹Ì±¹ ¾ÈÀüÀ§¿øÈ¸(NSC)´Â ¾Æ¸¶Á¸°ú Çù·ÂÇÏ¿© 50°³ ÀÌ»óÀÇ À¯¸í ±â¾÷À» ´ë»óÀ¸·Î ÇÑ 50¿© °³ÀÇ ¼³¹®Á¶»ç¸¦ ¹ÙÅÁÀ¸·Î ÇÑ 'MSD Solutions Index Pledge Community Report'¸¦ ¹ßÇ¥ÇÏ¿´½À´Ï´Ù. 50°³ ÁÖ¿ä ±â¾÷µéÀ» ´ë»óÀ¸·Î ÇÑ ¼³¹®Á¶»ç¸¦ ¹ÙÅÁÀ¸·Î ÇÑ À̹ø ºÐ¼®Àº ¿¬°£ ¾à 170¾ï ´Þ·¯ÀÇ ¼Õ½ÇÀ» ÃÊ·¡ÇÏ´Â °¡Àå ÈçÇÑ »ê¾÷ÀçÇØ ¿¹¹æ¿¡ ÀÖ¾î °í¹«ÀûÀÎ ¹ßÀü°ú °³¼±ÇØ¾ß ÇÒ Á¡µéÀ» ¸ðµÎ º¸¿©ÁÝ´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ ¼ö¼ú¿ë ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛ ½ÃÀåÀÇ ¼öÀÍÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

·Îº¿ ³»ºñ°ÔÀ̼ÇÀÇ ´ëÁßÈ­

·Îº¿ ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛÀº ¼ö¼ú Áß ¼ö¼ú±â±¸¸¦ À¯µµÇÒ ¶§ ³ôÀº Á¤¹Ðµµ¿Í Á¤È®µµ¸¦ Á¦°øÇÕ´Ï´Ù. ÷´Ü ¿µ»ó ±â¼ú°ú ½Ç½Ã°£ Çǵå¹éÀ» Ȱ¿ëÇÔÀ¸·Î½á, ÀÌ ½Ã½ºÅÛÀº ¿Ü°ú Àǻ簡 º¹ÀâÇÑ ÇØºÎÇÐÀû ±¸Á¶¸¦ º¸´Ù ¾ÈÁ¤ÀûÀ̰í Á¤È®ÇÏ°Ô Å½»öÇÒ ¼ö ÀÖµµ·Ï ÇÏ¿© ¿À·ù À§ÇèÀ» ÁÙÀÌ°í ¼ö¼ú °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, BLK-Max Super Specialty HospitalÀº 2022³â 12¿ù ¼ö¼úÀÇ ¾ÈÀü¼º°ú Á¤È®¼ºÀ» ³ôÀ̱â À§ÇØ Ã´Ãß ¼ö¼ú¿ë ÅëÇÕ ·Îº¿ ½Ã½ºÅÛÀ» ¹ßÇ¥Çß½À´Ï´Ù. ¶ÇÇÑ, ·Îº¿ ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛÀº ¿Ü°úÀǻ翡°Ô 3D À̹ÌÁö ¹× Áõ°­Çö½Ç(AR) ¿À¹ö·¹ÀÌ¿Í °°Àº Çâ»óµÈ ½Ã°¢È­ ±â´ÉÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Çâ»óµÈ ½Ã°¢È­´Â °ø°£Àû ¹æÇâ°ú ±íÀÌ ÀνÄÀ» Çâ»ó½ÃÄÑ ¼ö¼ú Áß º¸´Ù Á¤È®ÇÑ Å½»ö°ú Á¶Á÷ Á¶ÀÛÀ» ¿ëÀÌÇÏ°Ô ÇØÁÝ´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 9¿ù, 2D/3D À̹Ì¡, ¼ö¼ú¿ë ³»ºñ°ÔÀ̼Ç, ·Îº¿°øÇÐÀ» °áÇÕÇÑ ½Ã½ºÅÛÀ» ¼³°è ¹× Á¦Á¶ÇÏ´Â ÇÁ¶û½ºÀÇ ¼ºÀå ÁßÀÎ ¸ÞµðÅ×Å© ±â¾÷ À̼¾¼È ·Îº¸Æ½½º(eCential Robotics)´Â 3D À̹Ì¡, ³»ºñ°ÔÀ̼Ç, ·Îº¿°øÇÐ °¡ÀÌ´ø½º ½Ã½ºÅÛ¿¡ ´ëÇÑ FDA 510(k) ½ÂÀÎÀ» ¹Þ¾Ò½À´Ï´Ù. FDA 510(k) ½ÂÀÎÀ» ¹ßÇ¥ÇÏ¸ç ¹Ì±¹ ³» ÅëÇÕ ·Îº¿ Ç÷§ÆûÀÇ º¸±ÞÀ» È®½ÇÇÏ°Ô Çß½À´Ï´Ù. ÀÌ¿Í ÇÔ²², ¼ö¼ú¿ë ·Îº¿°ú º¹ÇÕÇö½Ç »ç¾÷À» Àü°³Çϰí ÀÖ´Â Á¦Å¸ ¼­ÁöÄÃÀº ½Ì°¡Æ÷¸£ ±¹¸³½Å°æ°úÇבּ¸¼Ò(NNI)¿¡¼­ ÁøÇàµÈ ÀÎü ½ÇÇè¿¡¼­ Á¦Å¸ µÎ°³°ñ ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛÀ¸·Î ù ȯÀÚ¸¦ ¼º°øÀûÀ¸·Î Ä¡·áÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº ¼ö¼ú¿ë ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛ ½ÃÀå Á¡À¯À²¿¡ ´õ¿í ±â¿©Çϰí ÀÖ½À´Ï´Ù.

Àúħ½ÀÀû ¼ö¼ú¹ý µµÀÔ Áõ°¡

ÃÖ¼Òħ½À¼ö¼úÀº ¼ö¼ú ºÎÀ§¿¡ ´ëÇÑ ½Ã¾ß¿Í Á¢±ÙÀÌ Á¦ÇÑÀûÀ̱⠶§¹®¿¡ Á¤È®ÇÑ ³×ºñ°ÔÀ̼ÇÀÌ ÇÊ¿äÇÕ´Ï´Ù. ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛÀº ½Ç½Ã°£ ¾È³»¿Í Çǵå¹éÀ» Á¦°øÇÏ¿© ¿Ü°úÀǻ簡 MIS ¼ö¼ú Áß º¹ÀâÇÑ ÇØºÎÇÐÀû ±¸Á¶¸¦ º¸´Ù Á¤È®ÇÏ°Ô Å½»öÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 8¿ù, ¼¼°èÀûÀΠôÃß ¹× Á¤Çü¿Ü°ú ±â¾÷ Orthofix Medical Inc.´Â ¹Ì±¹¿¡¼­ 7D FLASH Navigation System Percutaneous Module 2.0À» »ç¿ëÇÑ Ã¹ ¹øÂ° ½Ã¼úÀ» ½ÃÀÛ, ¿Ï·áÇß½À´Ï´Ù. Module 2.0Àº OrthofixÀÇ 7D FLASH ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛ¿¡ »õ·Î¿î °èȹ ±â´É°ú ±â´ÉÀ» Ãß°¡ÇÏ¿© ÃÖ¼Òħ½À¼ö¼ú(MIS) ôÃß ¾÷°è¿¡ ´õ ³ªÀº ¼­ºñ½º¸¦ Á¦°øÇÒ ¼ö ÀÖµµ·Ï Çß½À´Ï´Ù. ¶ÇÇÑ, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ½ÉÇ÷°ü¿Ü°ú, »êºÎÀΰú µî ´Ù¾çÇÑ ¼ö¼ú Àü¹® ºÐ¾ß¿¡¼­ ÃÖ¼Òħ½À ±â¼úÀÌ Á¡Á¡ ´õ ¸¹ÀÌ È°¿ëµÇ°í ÀÖ½À´Ï´Ù. ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛÀº ÀÌ·¯ÇÑ Àü¹® ºÐ¾ßÀÇ ´Ù¾çÇÑ ¿ä±¸¸¦ ÃæÁ·½ÃŰ¸ç ¿©·¯ ÀÓ»ó ºÐ¾ß¿¡ °ÉÃÄ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, Philips´Â 2024³â 2¿ù, ±¤¼¶À¯ ¸®¾ó½¦ÀÌÇÁ(FORS) ±â¼úÀ» äÅÃÇÏ¿© Ç÷°ü ¼ö¼ú¿¡¼­ X-¼±À» »ç¿ëÇÏÁö ¾Ê´Â ÃÖ¼Òħ½ÀÀû ¼ö¼úÀ» °¡´ÉÇÏ°Ô ÇÏ´Â ·ç¹Ì °¡À̵带 Ãâ½ÃÇß½À´Ï´Ù. ¶ÇÇÑ, ¹Ì±¹ FDA, À¯·´ CE ¸¶Å© µî ±ÔÁ¦ ±â°ü¿¡¼­ Àúħ½À ¼ö¼ú¿¡ »ç¿ëµÇ´Â ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛÀ» ½ÂÀÎÇß½À´Ï´Ù. ¸íÈ®ÇÑ ±ÔÁ¦ °æ·Î¿Í ½ÂÀÎÀº ¾ÈÀü¼º°ú À¯È¿¼ºÀ» º¸ÀåÇϰí, ÃÖ¼Òħ½À ¼ö¼ú¿¡¼­ ³»ºñ°ÔÀÌ¼Ç ±â¼úÀÇ Ã¤ÅÃÀ» ÃËÁøÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 5¿ù, ³ë¹Ù·Îµå´Â Àεµ³×½Ã¾Æ ½ÄǰÀǾàû(FDA)À¸·ÎºÎÅÍ ÃÖ¼Òħ½À ¼ö¼ú¿ë VisAR ¼ö¼ú¿ë ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛ ½ÂÀÎÀ» ¹Þ¾Ò½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº ¼ö¼ú¿ë ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛ ½ÃÀå ¿¹Ãø¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»ç ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • º¸ÅÒ¾÷ Á¢±Ù
    • Åé´Ù¿î Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼­·Ð

  • °³¿ä
  • ÁÖ¿ä ¾÷°è µ¿Çâ

Á¦5Àå ¼¼°èÀÇ ¼ö¼ú¿ë ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛ ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ºÐ¼® : ±â¼úº°

  • ÀüÀÚ ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ±¤ÇÐ Ç×¹ý ½Ã½ºÅÛ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ±âŸ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦7Àå ½ÃÀå ºÐ¼® : ¿ëµµº°

  • ³ú½Å°æ¿Ü°ú
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • Á¤Çü¿Ü°ú
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • À̺ñÀÎÈİú
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • Ä¡°ú
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ±âŸ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦8Àå ½ÃÀå ºÐ¼® : ÃÖÁ¾ ¿ëµµº°

  • º´¿ø
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦9Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ±âŸ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ºÐ¼® : ±¹°¡º°
    • ½ÃÀå ¿¹Ãø

Á¦10Àå ¼ºÀå ÃËÁø¿äÀÎ ¹× ¾ïÁ¦¿äÀΰú ±âȸ

  • °³¿ä
  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ±âȸ

Á¦11Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦12Àå PorterÀÇ Five Forces ºÐ¼®

  • °³¿ä
  • ¹ÙÀÌ¾î ±³¼··Â
  • °ø±Þ¾÷üÀÇ ±³¼··Â
  • °æÀï Á¤µµ
  • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦13Àå °¡°Ý ºÐ¼®

Á¦14Àå °æÀï ±¸µµ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • Amplitude Surgical
    • B. Braun SE
    • Brainlab AG
    • Collin Medical
    • Fudan Digital Medical
    • Johnson & Johnson
    • Medtronic PLC
    • Siemens Healthcare Private Limited
    • Stryker Corporation
    • Zimmer Biomet Holdings Inc.
LSH 25.02.19

The global surgical navigation systems market size reached USD 9.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 22.5 Billion by 2033, exhibiting a growth rate (CAGR) of 9.76% during 2025-2033. The rising burden of chronic diseases, the aging population, the growing need for minimally invasive (MI) procedures, and the integration of novel visualization technologies into surgical navigation systems represent some of the key factors driving the market growth.

Surgical Navigation Systems Market Analysis:

Major Market Drivers: The surging burden of chronic diseases, including cancer, orthopedic disorders, neurological conditions, etc., is primarily driving the market growth. Moreover, ongoing advancements in surgical navigation technology, such as improved imaging modalities, enhanced software algorithms, and augmented reality integration, are also propelling the market growth.

Key Market Trends: Integration of artificial intelligence (AI) and machine learning, growing inclination towards the development of portable and handheld navigation systems, rising advancement in imaging modalities, etc., are expected to proliferate the market demand. Furthermore, the surgical navigation system market is also expanding due to increasing healthcare infrastructure investments, rising demand for advanced medical technologies, and growing awareness among healthcare professionals.

Competitive Landscape: Some of the leading surgical navigation systems market companies are Amplitude Surgical, B. Braun SE, Brainlab AG, Collin Medical, Fudan Digital Medical, Johnson & Johnson, Medtronic PLC, Siemens Healthcare Private Limited, Stryker Corporation, and Zimmer Biomet Holdings Inc., among many others.

Geographical Trends: According to the report, North America accounted for the largest market share. North America acquired the most prominent share owing to various factors, such as the aging population, rising incidences of chronic diseases, escalating demand for surgical procedures, ongoing technological innovations, etc. North America is at the forefront of technological innovation in healthcare, and this applies to surgical navigation systems as well. Continuous advancements in navigation technology, such as improved imaging modalities, enhanced software algorithms, and integration with other surgical tools, drive the surgical navigation systems market demand.

Challenges and Opportunities: High initial cost of surgical navigation systems, complexity of integration, need for specialized training, and regulatory compliance are some of the key challenges that the market is facing. However, the integration of surgical navigation systems with robotic surgical platforms and digital surgery technologies presents numerous surgical navigation systems market opportunities for enhanced procedural accuracy, automation, and surgical efficiency. Collaborations between navigation system manufacturers and robotics companies can lead to innovative solutions for minimally invasive surgery, thereby supporting the industry's demand.

Surgical Navigation Systems Market Trends:

Surging Cases of Musculoskeletal and Neurological Disorders

As the global population ages, there's a natural increase in age-related conditions, such as osteoarthritis, degenerative disc disease, and neurological disorders like Alzheimer's and Parkinson's disease. The aging demographic contributes significantly to the rise in musculoskeletal and neurological disorders. For instance, according to the report published by the World Health Organization in July 2022, nearly 1.71 billion people suffer from musculoskeletal disease owing to the aging population. Apart from this, continuous advancements in surgical navigation technology, including improved imaging modalities, augmented reality integration, and AI-driven navigation algorithms, enhance the capabilities of these systems in addressing complex musculoskeletal and neurological cases. Surgeons are more inclined to adopt navigation systems with advanced features to improve patient outcomes. For instance, in December 2023, Quibim, a company leading imaging biomarkers for precision medicine launched QP-Brain. QP-Brain is a technology that uses artificial intelligence (AI) to automatically quantify, and present results based on the data from MRI Scans directly in PACS, making it easier to perform quantitative analysis on patients' brains for neurological disorders. Besides this, governments of various countries are taking initiatives in order to create awareness regarding musculoskeletal disorders in the workplace. For instance, in January 2024, the National Safety Council (NSC), in partnership with Amazon, launched the MSD Solutions Index Pledge Community Report, which highlights progress in reducing musculoskeletal disorders (MSDs) in the workplace. The analysis, based on a survey of over 50 prominent firms, identifies both encouraging developments and places for improvement in preventing the most prevalent workplace accident, which costs employers approximately US$ 17 Billion per year. These factors are bolstering the surgical navigation systems market revenue.

Rising Penetration of Robotic Navigation

Robot navigation systems offer high levels of precision and accuracy in guiding surgical instruments during procedures. By leveraging advanced imaging technologies and real-time feedback, these systems enable surgeons to navigate complex anatomical structures with greater confidence and precision, reducing the risk of errors and improving surgical outcomes. For instance, in December 2022, BLK-Max Super Specialty Hospital launched an integrated robotic system for spine surgeries in order to increase the safety and accuracy of the surgery. Moreover, robot navigation systems provide surgeons with enhanced visualization capabilities, including 3D imaging and augmented reality overlays. This improved visualization allows for better spatial orientation and depth perception, facilitating more precise navigation and tissue manipulation during surgery. For instance, in September 2022, eCential Robotics, a French growth MedTech company that designs and manufactures a system that combines 2D/3D imaging, surgical navigation, and robotics, announced FDA 510(k) clearance for its 3D imaging, navigation, and robotics guidance system, securing the penetration of its unified robotic platform in the United States. In line with this, Zeta Surgical, a surgical robotics and mixed reality business, successfully treated its first patient with the Zeta Cranial Navigation System during its first-in-human study at Singapore's National Neuroscience Institute (NNI). These factors are further contributing to the surgical navigation systems market share.

Increasing Adoption of Minimally Invasive Surgical Techniques

Minimally invasive surgical techniques require precise navigation due to limited visibility and access to the surgical site. Navigation systems provide real-time guidance and feedback, enabling surgeons to navigate complex anatomical structures with greater accuracy during MIS procedures. For instance, in August 2023, Orthofix Medical Inc., a global spine and orthopedics company, launched and completed the first cases in the United States using the 7D FLASH Navigation System Percutaneous Module 2.0. The Percutaneous Module 2.0 adds new planning capabilities and capability to Orthofix's 7D FLASH Navigation System, allowing it to better serve the Minimally Invasive Surgery (MIS) spine industry. Moreover, minimally invasive techniques are being increasingly utilized across various surgical specialties, including orthopedics, neurosurgery, cardiovascular surgery, and gynecology. Navigation systems accommodate the diverse needs of these specialties, driving the market growth across multiple clinical areas. For instance, in February 2024, Philips launched LumiGuide, which uses Fiber Optic RealShape (FORS) technology to enable minimally invasive surgery without the use of X-ray radiation for vascular surgery. Furthermore, regulatory agencies, such as the FDA in the United States and the CE mark in Europe, approved navigation systems for use in minimally invasive surgeries. Clear regulatory pathways and approvals provide assurance of safety and efficacy, encouraging the adoption of navigation technology in minimally invasive procedures. For instance, in May 2023, Novarad received approval from Indonesia's Food and Drug Administration (FDA) for VisAR surgical navigation system for minimally invasive surgery. These factors are positively influencing the surgical navigation systems market forecast.

Surgical Navigation Systems Industry Segmentation:

Breakup by Technology:

Electromagnetic Navigation Systems

Optical Navigation Systems

Others

Electromagnetic navigation systems dominates the market

Electromagnetic navigation systems are valuable tools used in surgical navigation systems across various medical fields. These systems utilize electromagnetic fields to track the position of instruments or devices within the body, providing real-time guidance to surgeons during procedures. Moreover, surgeons can use electromagnetic navigation systems during the pre-operative phase to plan surgical approaches and trajectories. By overlaying imaging data (such as CT scans or MRI) onto a computer-generated model of the patient's anatomy, surgeons can simulate the procedure and determine the optimal path for instrument insertion. For instance, in May 2024, Centerline Biomedical, Inc., was awarded a MedTech Outlook Award as a 2024 top surgical devices company. The company is known for Revolutionizing Interventional Procedures with IOPS Technology. Endovascular surgeries benefit from IOPS's innovative 3D visualization, electromagnetic navigation, and radiation safety features.

Breakup by Application:

Neurosurgery

Orthopedic

ENT

Dental

Others

Neurosurgery hold the largest share in the market

As per the surgical navigation systems market outlook, surgical navigation systems have revolutionized neurosurgery by providing neurosurgeons with advanced tools for precise planning and execution of complex procedures involving the brain and spine. It assists neurosurgeons in accurately locating and delineating brain tumors, even those deep within the brain. By overlaying pre-operative imaging onto the patient's anatomy in real-time, surgeons can precisely navigate to the tumor, minimizing damage to surrounding healthy brain tissue. For instance, in January 2024, Zeta Surgical, a surgical robotics and mixed reality firm, received FDA special 510(k) clearance for increased features and expanded compatibility with their cranial navigation system for neurosurgery.

Breakup by End User:

Hospitals

Ambulatory Surgical Centers

Hospitals accounts for the majority of the market share

Surgical navigation systems are increasingly being used in hospitals for various procedures, especially those involving delicate or intricate surgeries. Surgeons can use surgical navigation systems to plan the surgery before entering the operating room. This involves reviewing medical images such as CT scans, MRI scans, or ultrasound to map out the procedure and identify critical structures. In addition, during surgery, navigation systems provide real-time feedback to the surgeon, helping them navigate through complex anatomical structures with precision. This guidance can be particularly useful in minimally invasive procedures where the surgeon's direct line of sight may be limited. For instance, in January 2024, AdventHealth for Children, a nationally recognized children's hospital and pediatric specialty network situated in Central Florida, successfully completed cranial vault reconstruction for craniosynostosis using the VisAR augmented reality surgical navigation system.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include Europe (Italy, Germany, France, Spain, the United Kingdom, Russia, and others); North America (the United States and Canada); Asia Pacific (China, Japan, Australia, South Korea, Indonesia, India, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

According to the surgical navigation systems market overview, North America is a hub for technological innovation in healthcare. Continuous advancements in surgical navigation technologies, such as the integration of artificial intelligence (AI), augmented reality (AR), and machine learning algorithms, are enhancing the precision, efficiency, and safety of surgical procedures. These innovations drive demand for advanced surgical navigation systems in the region. Moreover, the rising prevalence of chronic diseases, such as cardiovascular diseases, cancer, and orthopedic disorders, is driving the demand for surgical interventions. Surgical navigation systems play a crucial role in performing complex surgeries with greater accuracy and precision, leading to better patient outcomes and reduced post-operative complications. For instance, in May 2023, Novarad, a U.S.-based medical device company, received approval from Indonesia's Food and Drug Administration (FDA) for VisAR surgical navigation system for minimally invasive surgery.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global surgical navigation systems market. Detailed profiles of all major companies have been provided. Some of the companies covered include:

Amplitude Surgical

B. Braun SE

Brainlab AG

Collin Medical

Fudan Digital Medical

Johnson & Johnson

Medtronic PLC

Siemens Healthcare Private Limited

Stryker Corporation

Zimmer Biomet Holdings Inc.

Key Questions Answered in This Report:

  • How has the global surgical navigation systems market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global surgical navigation systems market?
  • What is the impact of each driver, restraint, and opportunity on the global surgical navigation systems market?
  • What are the key regional markets?
  • Which countries represent the most attractive surgical navigation systems market?
  • What is the breakup of the market based on technology?
  • Which is the most attractive technology in the surgical navigation systems market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the surgical navigation systems market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the surgical navigation systems market?
  • What is the competitive structure of the global surgical navigation systems market?
  • Who are the key players/companies in the global surgical navigation systems market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Surgical Navigation Systems Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 Electromagnetic Navigation Systems
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Optical Navigation Systems
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Neurosurgery
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Orthopedic
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 ENT
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Dental
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Amplitude Surgical
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 B. Braun SE
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Brainlab AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Collin Medical
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Fudan Digital Medical
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Johnson & Johnson
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Medtronic PLC
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Siemens Healthcare Private Limited
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Stryker Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Zimmer Biomet Holdings Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦